Intelligent Imaging Innovations, Inc.

Intelligent Imaging Innovations, Inc., doing business as 3 I, a Denver-based for-profit manufacturer of advanced microscopy equipment and imaging software, holds 53 prime federal contracts and 2 subcontracts (96% prime / 4% sub split) across the National Institutes of Health ecosystem, NASA, and the Department of Veterans Affairs, competing in full-and-open procurements without set-aside designations. The vendor has recorded $5.8 million in combined potential value and $7.8 million in obligated dollars across 55 recent awards spanning equipment sales, maintenance and upgrade services, and product development.

3 I's customer base concentrates heavily within NIH. The National Cancer Institute dominates by dollar value (10 awards, $1.8 million combined potential value) and serves as a repeat purchaser for Marianas Super-Resolution Spinning Disk Confocal systems, Lattice Light Sheet microscopes, and ongoing maintenance agreements. The National Institute of Child Health and Human Development leads by award count (13 awards, $405 thousand), followed by the National Heart, Lung, and Blood Institute (5 awards, $473 thousand), and the National Institute on Drug Abuse (5 awards, $219 thousand). These five agencies account for 65% of all recent awards. NASA's Shared Services Center ranks third by potential value ($791 thousand across 2 awards), anchored by a $749,527 STTR Phase II contract for the REALISE remote experimentation platform in space. 3 I also serves the National Institute of Neurological Disorders and Stroke, National Institute on Deafness and Other Communication Disorders, National Institute of Mental Health, and the Department of Veterans Affairs.

Representative prime work includes a $596,977.92 sole-source purchase order from the National Cancer Institute for a Marianas Super-Resolution Spinning Disk Confocal system with proprietary C-Shaper adaptive optics for 3D organoid imaging; a $503,834.10 light sheet microscopy imaging system for the National Institute on Alcohol Abuse and Alcoholism; a $249,996.14 Vector TIRF3 microscope for single-molecule research at the National Heart, Lung, and Blood Institute; and a $141,726.05 purchase order from the National Institute of Neurological Disorders and Stroke for three Andor iXON 888 EMCCD cameras with Oasis 160 chillers. 3 I also carries equipment maintenance and upgrade contracts, such as a $190,000 base-period maintenance agreement with the National Cancer Institute (effective through August 2025) and a $121,125 three-year maintenance agreement with NCI Bethesda (April 2026 – March 2029). Recent grant work includes a Phase I Small Business Innovative Research award from the National Institute of Mental Health (January 2025 – December 2026) to develop high-bandwidth all-optical electrophysiology instrumentation combining volumetric neural imaging and optogenetic stimulation.

3 I subcontracts to Roche Diagnostics Corporation on COVID-19 serology testing and microscopy systems integration work. The vendor sits on a single identified parent IDV (Indefinite Delivery Contract 75N91019D00038) with 2 task orders. Award trajectory remains modest and flat — 5 awards in both 2022 and 2023, 8 in 2024, 3 in 2025, and 2 through April 2026 — with only 2 awards (combined potential value $25 thousand) reaching ultimate completion within the next twenty-four months, presenting minimal near-term recompete exposure. The vendor's primary NAICS footprint splits evenly between Analytical Laboratory Instrument Manufacturing and Other Electronic and Precision Equipment Repair and Maintenance (13 awards each), with secondary presence in Software Publishers (6 awards) and Custom Computer Programming Services (4 awards). Most awards carry no small business set-aside; sole-source determinations based on proprietary technology appear in several high-value awards, particularly those specifying 3 I's C-Shaper, Lattice Light Sheet, or TIRF systems as unique sources.